Stockchase Discover Atossa Therapeutics ATOS-Q BUY Jul 13, 2021

Allan Tong’s Discover Picks Two analysts rate ATOS stock a buy with a price target of $7.50 or 41% upside. Again, this is purely a speculative play and a volatile one with a 2.21 beta though it is a recovery stock. Fundamentals are spotty with insufficient data on Atossa’s margins and price earnings, so you’re betting on AT-H201, much like the market was wagering on who would win the vaccine sweepstakes 16 months ago. Read 3 Post-Covid Recovery Stocks to Buy for our full analysis.